JPRN-UMIN000042408
Completed
未知
Prospective clinical study of comprehensive genomic profiling for patients with chemotherapy-naive advanced cancer. - FIRST-Dx trial
Conditionsadvanced cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- advanced cancer
- Sponsor
- Kyoto University Hospital
- Enrollment
- 182
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Inappropriate for trial due to mental disease. Inappropriate for trial judged by medical doctors.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Genomic evaluation in patients with diffuse large B cell lymphomaKCT0003963Samsung Medical Center200
Unknown
Not Applicable
Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer CareMetastatic CancerAdvanced CancerCancers That Cannot be Treated With Curative IntentNCT04141397British Columbia Cancer Agency1,200
Recruiting
Not Applicable
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDSWhole Genome SequencingAcute Myeloid LeukemiaMyelodysplastic SyndromesNCT04986657Washington University School of Medicine325
Recruiting
Not Applicable
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDSWhole Genome SequencingMyelodysplastic SyndromesNCT05434598Washington University School of Medicine60
Active, not recruiting
Not Applicable
The usefulness of whole genome sequencing in diagnosis and clinical management of drug-resistant tuberculosis patients in TanzaniaApplication of whole genome sequencing in multidrug resistance tuberculosis patientsInfections and InfestationsISRCTN14635089Tanzania Commission for Science and Technology153